{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:56:06Z","timestamp":1791975366369,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1D1A1B07044100"],"award-info":[{"award-number":["NRF-2018R1D1A1B07044100"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Beh\u00e7et\u2019s disease (BD) is a chronic inflammatory disease. Low levels of plasma high-density lipoprotein cholesterol (HDL-C) are associated with Crohn\u2019s disease, another chronic inflammatory disease. However, the effects of low HDL-C levels on BD are unclear. We investigated the effects of HDL-C levels, and variability therein, on the risk for BD. We used the Korean National Health Insurance System database to identify 5,587,754 adults without a history of BD who underwent\u2009\u2265\u20093 medical examinations between 2010 and 2013. Mean HDL-C levels at each visit were used to calculate variability independent of the mean (VIM) and the coefficient of variation (CV). There were 676 new cases of BD (0.012%). The risk for BD was increased in participants with highly variable and low mean HDL-C levels. In a multivariate-adjusted model, the hazard ratios (95% confidence intervals) for BD incidence were 1.335 (1.058\u20131.684) in a high mean\/high VIM group, 1.527 (1.211\u20131.925) in a low mean\/low VIM group, and 2.096 (1.67\u20132.63) in a low mean\/high VIM group compared to a high mean\/low VIM group. Low mean HDL-C levels, and high variability therein, are independent risk factors for BD.<\/jats:p>","DOI":"10.1038\/s41598-022-17096-0","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T06:20:26Z","timestamp":1658989226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk for Beh\u00e7et\u2019s disease gauged via high-density lipoprotein cholesterol: a nationwide population-based study in Korea"],"prefix":"10.1038","volume":"12","author":[{"given":"Yeong Ho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"17096_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane, T., Takeno, M., Suzuki, N. & Inaba, G. Behcet\u2019s disease. N. Engl. J. Med. 341, 1284\u20131291 (1999).","journal-title":"N. Engl. J. Med."},{"key":"17096_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"DH Verity","year":"1999","unstructured":"Verity, D. H., Marr, J. E., Ohno, S., Wallace, G. R. & Stanford, M. R. Behcet\u2019s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54, 213\u2013220 (1999).","journal-title":"Tissue Antigens"},{"key":"17096_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/jdv.14601","volume":"32","author":"YB Lee","year":"2018","unstructured":"Lee, Y. B. et al. Incidence, prevalence, and mortality of Adamantiades-Behcet\u2019s disease in Korea: a nationwide, population-based study (2006\u20132015). J. Eur. Acad. Dermatol. Venereol. 32, 999\u20131003 (2018).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"17096_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"MP de Chambrun","year":"2012","unstructured":"de Chambrun, M. P., Wechsler, B., Geri, G., Cacoub, P. & Saadoun, D. New insights into the pathogenesis of Behcet\u2019s disease. Autoimmun. Rev. 11, 687\u2013698 (2012).","journal-title":"Autoimmun. Rev."},{"key":"17096_CR5","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/CIRCULATIONAHA.113.000962","volume":"128","author":"RS Rosenson","year":"2013","unstructured":"Rosenson, R. S. et al. Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges. Circulation 128, 1256\u20131267 (2013).","journal-title":"Circulation"},{"key":"17096_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1056\/NEJMe1012520","volume":"364","author":"J Heinecke","year":"2011","unstructured":"Heinecke, J. HDL and cardiovascular-disease risk\u2013time for a new approach?. N. Engl. J. Med. 364, 170\u2013171 (2011).","journal-title":"N. Engl. J. Med."},{"key":"17096_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015493","volume":"9","author":"BH Han","year":"2020","unstructured":"Han, B. H., Han, K., Yoon, K. H., Kim, M. K. & Lee, S. H. Impact of mean and variability of high-density lipoprotein-cholesterol on the risk of myocardial infarction, stroke, and mortality in the general population. J. Am. Heart Assoc. 9, e015493 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"17096_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jacl.2017.12.003","volume":"12","author":"DD Waters","year":"2018","unstructured":"Waters, D. D. et al. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events. J. Clin. Lipidol. 12, 356\u2013366 (2018).","journal-title":"J. Clin. Lipidol."},{"key":"17096_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2015.10.110","volume":"244","author":"E Boey","year":"2016","unstructured":"Boey, E. et al. Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up study. Atherosclerosis 244, 86\u201392 (2016).","journal-title":"Atherosclerosis"},{"key":"17096_CR10","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1093\/eurheartj\/ehx585","volume":"38","author":"MK Kim","year":"2017","unstructured":"Kim, M. K. et al. Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study. Eur. Heart J. 38, 3560\u20133566 (2017).","journal-title":"Eur. Heart J."},{"key":"17096_CR11","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1210\/jc.2019-01080","volume":"104","author":"SH Lee","year":"2019","unstructured":"Lee, S. H. et al. HDL-cholesterol, its variability, and the risk of diabetes: a nationwide population-based study. J. Clin. Endocrinol. Metab. 104, 5633\u20135641 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"17096_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","volume":"9","author":"C Mendoza-Pinto","year":"2010","unstructured":"Mendoza-Pinto, C. et al. Etiopathogenesis of Behcet\u2019s disease. Autoimmun. Rev. 9, 241\u2013245 (2010).","journal-title":"Autoimmun. Rev."},{"key":"17096_CR13","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s10067-006-0449-1","volume":"26","author":"M Caliskan","year":"2007","unstructured":"Caliskan, M. et al. Endothelial functions are more severely impaired during active disease period in patients with Behcet\u2019s disease. Clin. Rheumatol. 26, 1074\u20131078 (2007).","journal-title":"Clin. Rheumatol."},{"key":"17096_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5114\/aoms.2018.79139","volume":"16","author":"C Yucel","year":"2020","unstructured":"Yucel, C. et al. Evaluation of atherogenic laboratory markers in Behcet\u2019s disease patients with vascular involvement. Arch. Med. Sci. 16, 531\u2013537 (2020).","journal-title":"Arch. Med. Sci."},{"key":"17096_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/apt.15562","volume":"51","author":"H Soh","year":"2020","unstructured":"Soh, H. et al. Crohn\u2019s disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population-based study. Aliment Pharmacol. Ther. 51, 446\u2013456 (2020).","journal-title":"Aliment Pharmacol. Ther."},{"key":"17096_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","volume":"10","author":"B Tong","year":"2019","unstructured":"Tong, B., Liu, X., Xiao, J. & Su, G. Immunopathogenesis of Behcet\u2019s Disease. Front. Immunol. 10, 665 (2019).","journal-title":"Front. Immunol."},{"key":"17096_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00011-018-1129-8","volume":"67","author":"S Jamwal","year":"2018","unstructured":"Jamwal, S. & Sharma, S. Vascular endothelium dysfunction: a conservative target in metabolic disorders. Inflamm. Res. 67, 391\u2013405 (2018).","journal-title":"Inflamm. Res."},{"key":"17096_CR18","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.2174\/138161210791051013","volume":"16","author":"C Besler","year":"2010","unstructured":"Besler, C., Heinrich, K., Riwanto, M., L\u00fcscher, T. F. & Landmesser, U. High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease. Curr. Pharm. Des. 16, 1480\u20131493 (2010).","journal-title":"Curr. Pharm. Des."},{"key":"17096_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.108.836346","volume":"121","author":"SA Sorrentino","year":"2010","unstructured":"Sorrentino, S. A. et al. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 121, 110\u2013122 (2010).","journal-title":"Circulation"},{"key":"17096_CR20","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/jama.2009.1346","volume":"302","author":"M Charakida","year":"2009","unstructured":"Charakida, M. et al. Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome. JAMA 302, 1210\u20131217 (2009).","journal-title":"JAMA"},{"key":"17096_CR21","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","volume":"31","author":"AJ Murphy","year":"2011","unstructured":"Murphy, A. J. et al. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 1333\u20131341 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"17096_CR22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3389\/fimmu.2018.01013","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Anti-inflammatory effects of HDL in mice with rheumatoid arthritis induced by collagen. Front. Immunol. 9, 1013 (2018).","journal-title":"Front. Immunol."},{"issue":"4","key":"17096_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4081\/reumatismo.2010.266","volume":"62","author":"A Scanu","year":"2011","unstructured":"Scanu, A. et al. HDL inhibit cytokine production in a mouse model of urate crystal-induced inflammation. Reumatismo 62(4), 266\u2013272 (2011).","journal-title":"Reumatismo"},{"key":"17096_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejphar.2017.12.050","volume":"821","author":"N Zhang","year":"2018","unstructured":"Zhang, N. et al. Statins reduce the expressions of Tim-3 on NK cells and NKT cells in atherosclerosis. Eur. J. Pharmacol. 821, 49\u201356 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"17096_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/pgmj.2004.025601","volume":"81","author":"GD Kolovou","year":"2005","unstructured":"Kolovou, G. D., Anagnostopoulou, K. K. & Cokkinos, D. V. Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgrad. Med. J. 81, 358\u2013366 (2005).","journal-title":"Postgrad. Med. J."},{"key":"17096_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.10.012","volume":"279","author":"EY Lee","year":"2018","unstructured":"Lee, E. Y. et al. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention. Atherosclerosis 279, 1\u20139 (2018).","journal-title":"Atherosclerosis"},{"key":"17096_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.05.018","volume":"286","author":"ES Koh","year":"2019","unstructured":"Koh, E. S. et al. Intra-individual variability in high density lipoprotein cholesterol and risk of end-stage renal disease: A nationwide population-based study. Atherosclerosis 286, 135\u2013141 (2019).","journal-title":"Atherosclerosis"},{"key":"17096_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/HCO.0000000000000627","volume":"34","author":"WG Simpson","year":"2019","unstructured":"Simpson, W. G. Biomarker variability and cardiovascular disease residual risk. Curr. Opin. Cardiol. 34, 413\u2013417 (2019).","journal-title":"Curr. Opin. Cardiol."},{"key":"17096_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","volume":"8","author":"M Navab","year":"2011","unstructured":"Navab, M., Reddy, S. T., Van Lenten, B. J. & Fogelman, A. M. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat. Rev. Cardiol. 8, 222\u2013232 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"17096_CR30","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2174\/092986708785747481","volume":"15","author":"A Kakafika","year":"2008","unstructured":"Kakafika, A., Athyros, V. G., Tziomalos, K., Karagiannis, A. & Mikhailidis, D. P. High density lipoprotein cholesterol and statin trials. Curr. Med. Chem. 15, 2265\u20132270 (2008).","journal-title":"Curr. Med. Chem."},{"key":"17096_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/MJT.0b013e318169bc0b","volume":"15","author":"V Bermudez","year":"2008","unstructured":"Bermudez, V. et al. Pharmacologic management of isolated low high-density lipoprotein syndrome. Am. J. Ther. 15, 377\u2013388 (2008).","journal-title":"Am. J. Ther."},{"key":"17096_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3949\/ccjm.70.6.553","volume":"70","author":"M Miller","year":"2003","unstructured":"Miller, M. Raising an isolated low HDL-C level: why, how, and when?. Cleve Clin. J. Med. 70, 553\u2013560 (2003).","journal-title":"Cleve Clin. J. Med."},{"key":"17096_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4093\/dmj.2018.42.2.93","volume":"42","author":"SH Ko","year":"2018","unstructured":"Ko, S. H. et al. Past and current status of adult type 2 diabetes mellitus management in Korea: a National Health Insurance Service Database analysis. Diabetes Metab. J. 42, 93\u2013100 (2018).","journal-title":"Diabetes Metab. J."},{"key":"17096_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4093\/dmj.2016.40.1.79","volume":"40","author":"YH Lee","year":"2016","unstructured":"Lee, Y. H. et al. Data analytic process of a nationwide population-based study using National Health Information Database established by National Health Insurance Service. Diabetes Metab. J. 40, 79\u201382 (2016).","journal-title":"Diabetes Metab. J."},{"key":"17096_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3803\/EnM.2014.29.4.405","volume":"29","author":"MK Kim","year":"2014","unstructured":"Kim, M. K. et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol. Metab. (Seoul) 29, 405\u2013409 (2014).","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"17096_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","volume":"38","author":"SO Song","year":"2014","unstructured":"Song, S. O. et al. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab. J. 38, 395\u2013403 (2014).","journal-title":"Diabetes Metab. J."},{"key":"17096_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/HYPERTENSIONAHA.111.00138","volume":"61","author":"K Asayama","year":"2013","unstructured":"Asayama, K. et al. Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension 61, 61\u201369 (2013).","journal-title":"Hypertension"},{"key":"17096_CR38","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/STROKEAHA.115.009076","volume":"46","author":"K Fukuda","year":"2015","unstructured":"Fukuda, K. et al. Day-by-day blood pressure variability and functional outcome after acute Ischemic stroke: Fukuoka Stroke Registry. Stroke 46, 1832\u20131839 (2015).","journal-title":"Stroke"},{"key":"17096_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/01.hjh.0000160205.81652.5a","volume":"23","author":"L Mena","year":"2005","unstructured":"Mena, L. et al. A reliable index for the prognostic significance of blood pressure variability. J. Hypertens 23, 505\u2013511 (2005).","journal-title":"J. Hypertens"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17096-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:45:18Z","timestamp":1669351518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17096-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17096"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17096-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"21 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12735"}}